> For the complete documentation index, see [llms.txt](https://www.thiamine.wiki/llms.txt). Markdown versions of documentation pages are available by appending `.md` to page URLs; this page is available as [Markdown](https://www.thiamine.wiki/biochemistry/oxidative-decarboxylation.md).

# oxidative decarboxylation

{% hint style="info" %}
**Section:** Complete Biochemistry → Coenzyme Pathways\
**Reading level:** Technical, with a plain-language summary\
**Last reviewed:** October 2026 · **Evidence status:** Well established (mechanism); moderate (role in specific diseases)
{% endhint %}

## Summary

**Oxidative decarboxylation** is the reaction in which a keto acid loses carbon dioxide and is simultaneously oxidized, producing an energy-rich acyl-CoA and NADH. In human mitochondria, it is carried out by four giant multi-enzyme machines, the **2-oxo acid dehydrogenase complexes**. They control the entry of carbohydrate into the Krebs cycle, the flow of the Krebs cycle itself, and the breakdown of several amino acids.

Each complex needs **five cofactors** derived from vitamins or synthesized in the body: thiamine pyrophosphate (from vitamin B1), lipoic acid, coenzyme A (from pantothenic acid, B5), FAD (from riboflavin, B2) and NAD⁺ (from niacin, B3). Thiamine acts at the first and usually rate-limiting step. When TPP is lacking, the whole complex slows.

## The overall reaction

**R–CO–COO⁻ + CoA–SH + NAD⁺ → R–CO–S–CoA + CO₂ + NADH**

The reaction releases a large amount of free energy and is effectively **irreversible** in cells. This makes each complex a committed, highly regulated step.

## The four human complexes

| Complex                                              | Substrate                                                     | Product                                             | E1 (TPP-dependent)   | E2 (lipoyl acyltransferase) | E3  | Core architecture                                     |
| ---------------------------------------------------- | ------------------------------------------------------------- | --------------------------------------------------- | -------------------- | --------------------------- | --- | ----------------------------------------------------- |
| **Pyruvate dehydrogenase (PDHc)**                    | Pyruvate                                                      | Acetyl-CoA                                          | PDHA1/PDHB (α₂β₂)    | DLAT                        | DLD | Icosahedral core of E2 with E3-binding protein (PDHX) |
| **2-Oxoglutarate dehydrogenase (OGDHc)**             | 2-Oxoglutarate (α-ketoglutarate)                              | Succinyl-CoA                                        | OGDH (homodimer)     | DLST                        | DLD | Octahedral 24-subunit E2 core                         |
| **Branched-chain α-ketoacid dehydrogenase (BCKDHc)** | α-Ketoisocaproate, α-keto-β-methylvalerate, α-ketoisovalerate | Isovaleryl-CoA, α-methylbutyryl-CoA, isobutyryl-CoA | BCKDHA/BCKDHB (α₂β₂) | DBT                         | DLD | Octahedral 24-subunit E2 core                         |
| **2-Oxoadipate dehydrogenase (OADHc)**               | 2-Oxoadipate                                                  | Glutaryl-CoA                                        | DHTKD1 (E1a)         | Shares DLST with OGDHc      | DLD | Assembles with OGDHc components                       |

All four share the same **E3, dihydrolipoamide dehydrogenase (DLD)**. DLD also serves the glycine cleavage system.

## Step by step

{% stepper %}
{% step %}

## E1: decarboxylation (TPP)

The TPP ylide attacks the keto acid's carbonyl carbon. The adduct loses **CO₂**, leaving an enamine–carbanion intermediate on TPP.
{% endstep %}

{% step %}

## E1: reductive acylation (TPP → lipoamide)

The intermediate is oxidized as it transfers its acyl group to the **oxidized lipoyl group** (a disulfide) on an E2 lipoyl domain. This forms **S-acyl-dihydrolipoamide** and regenerates free TPP.
{% endstep %}

{% step %}

## E2: acyl transfer (lipoamide → CoA)

E2 transfers the acyl group from dihydrolipoamide to **coenzyme A**, releasing the acyl-CoA product (acetyl-CoA, succinyl-CoA and so on) and leaving reduced dihydrolipoamide.
{% endstep %}

{% step %}

## E3: reoxidation (FAD → NAD⁺)

E3 reoxidizes dihydrolipoamide back to its disulfide form using bound **FAD**. The electrons are then passed to **NAD⁺**, producing **NADH**, which feeds the respiratory chain.
{% endstep %}
{% endstepper %}

### The vitamin cofactors at a glance

| Cofactor                | Vitamin origin              | Where it acts |
| ----------------------- | --------------------------- | ------------- |
| Thiamine pyrophosphate  | B1 (thiamine)               | E1            |
| Lipoic acid (lipoamide) | Synthesized in mitochondria | E2            |
| Coenzyme A              | B5 (pantothenic acid)       | E2            |
| FAD                     | B2 (riboflavin)             | E3            |
| NAD⁺                    | B3 (niacin)                 | E3            |

## Substrate channelling: the swinging arm

The lipoyl group is attached to a lysine on a small, mobile **lipoyl domain** connected to the E2 core by flexible linkers. Together, the lipoyl-lysine and the domain linkers allow the acyl group to be carried between the active sites of E1, E2 and E3 without being released. This "swinging arm" arrangement:

* prevents loss of reactive intermediates;
* allows very high local concentrations of substrates;
* lets each E1 serve many E2 sites (active-site coupling).

## Bioenergetic significance

* **PDHc** is the main gateway for glucose-derived carbon into the Krebs cycle. It determines whether pyruvate is oxidized or diverted to lactate, alanine or gluconeogenesis.
* **OGDHc** is a major control point of the Krebs cycle. Its product, succinyl-CoA, supports substrate-level phosphorylation (via succinyl-CoA synthetase) and heme synthesis.
* **BCKDHc** commits branched-chain amino acids to oxidation.
* Each complex produces **NADH**, which drives ATP synthesis.

## Reactive oxygen species: generator and target

Studies in isolated mitochondria show that the E3 component of **OGDHc and PDHc** can generate superoxide and hydrogen peroxide, particularly when the NADH/NAD⁺ ratio is high. OGDHc is also **inactivated by oxidative stress**. This dual role has been proposed to contribute to energy failure in thiamine deficiency and in neurodegenerative disease. Its quantitative importance in intact tissues is still debated.

## What happens in thiamine deficiency

When TPP is insufficient, E1 activity falls, and flux through each complex declines.

| Consequence                                     | Mechanism                                                       | Clinical or experimental correlate                                      |
| ----------------------------------------------- | --------------------------------------------------------------- | ----------------------------------------------------------------------- |
| **Pyruvate and lactate accumulate**             | Reduced PDHc flux                                               | Lactic acidosis (for example, in Shoshin beriberi and critical illness) |
| **Reduced ATP production**                      | Less acetyl-CoA and slowed Krebs cycle                          | Energy failure in high-demand tissues                                   |
| **2-Oxoglutarate accumulates; glutamate rises** | Reduced OGDHc flux                                              | Proposed glutamate excitotoxicity in Wernicke lesions                   |
| **Reduced acetyl-CoA for acetylcholine**        | Reduced PDHc flux                                               | Proposed contribution to cognitive symptoms                             |
| **Oxidative stress**                            | Altered NADH balance; reduced transketolase-linked NADPH        | Markers of oxidative damage in experimental thiamine deficiency         |
| **Selective brain lesions**                     | Regional differences in metabolic rate and enzyme vulnerability | Thalamic, mammillary and periventricular damage                         |

Animal studies show that reductions in α-ketoglutarate dehydrogenase activity in vulnerable brain regions precede the appearance of lesions. This supports a causal role for impaired oxidative decarboxylation in Wernicke encephalopathy.

## Related disorders and toxins

| Condition                         | Mechanism                                                                       | Relevance to thiamine                                         |
| --------------------------------- | ------------------------------------------------------------------------------- | ------------------------------------------------------------- |
| **PDH deficiency**                | Inherited defect, usually in *PDHA1*                                            | Some variants respond to thiamine; ketogenic diets bypass PDH |
| **MSUD**                          | Inherited BCKDH defect                                                          | Some variants respond to thiamine                             |
| **DLD (E3) deficiency**           | Affects all four complexes and glycine cleavage                                 | Shows the shared dependence on E3                             |
| **Lipoic acid synthesis defects** | Lack of functional E2 lipoyl groups                                             | Combined complex deficiency; not thiamine-responsive          |
| **Arsenite poisoning**            | Binds the dithiol of reduced lipoamide                                          | Classic biochemical mechanism of arsenic toxicity             |
| **Primary biliary cholangitis**   | Autoantibodies (anti-mitochondrial antibodies) targeting the E2 subunit of PDHc | Diagnostic marker; not a thiamine disorder                    |

## Evidence quality

| Claim type                                                | Strength                                                       |
| --------------------------------------------------------- | -------------------------------------------------------------- |
| Complex composition, cofactors and reaction steps         | **Strong**                                                     |
| Swinging-arm channelling                                  | **Strong**: structural and kinetic evidence                    |
| ROS production by E3 in isolated systems                  | **Strong** in vitro; **moderate** for physiological importance |
| α-KGDH reduction preceding lesions in thiamine deficiency | **Moderate**: consistent animal data                           |
| Glutamate excitotoxicity in human Wernicke lesions        | **Moderate to limited**: largely inferred from animal models   |

## Open questions

* How much each complex contributes to tissue damage in human thiamine deficiency.
* Whether ROS production by OGDHc and PDHc matters in living tissue, and whether TPP status modifies it.
* How DHTKD1 interacts with OGDHc components in cells, and its role in neuropathy.

## Related pages

* [TPP-Dependent Enzymes](broken://pages/48b61d9218e12eeb5f0e1876c67ae5de17b143ff)
* [Ketoacid Metabolism](broken://pages/8854c82e2c5b69bab22dce371bbcd188a3d75c33)
* [Pentose Phosphate Pathway](broken://pages/63cc26a45948f6188857defdc77e37bfecabe456)
* [How the Body Uses Thiamine](broken://pages/872a650978cf246c1fb7aaf4f07e0870abf2dab1)

## References

1. Perham RN. Swinging arms and swinging domains in multifunctional enzymes: catalytic machines for multistep reactions. *Annual Review of Biochemistry*. 2000;69:961–1004.
2. Patel MS, Nemeria NS, Furey W, Jordan F. The pyruvate dehydrogenase complexes: structure-based function and regulation. *Journal of Biological Chemistry*. 2014;289(24):16615–16623.
3. Starkov AA, et al. Mitochondrial α-ketoglutarate dehydrogenase complex generates reactive oxygen species. *Journal of Neuroscience*. 2004;24(36):7779–7788.
4. Tretter L, Adam-Vizi V. Generation of reactive oxygen species in the reaction catalyzed by α-ketoglutarate dehydrogenase. *Journal of Neuroscience*. 2004;24(36):7771–7778.
5. Tretter L, Adam-Vizi V. Alpha-ketoglutarate dehydrogenase: a target and generator of oxidative stress. *Philosophical Transactions of the Royal Society B*. 2005;360(1464):2335–2345.
6. Hazell AS, Butterworth RF. Update of cell damage mechanisms in thiamine deficiency: focus on oxidative stress, excitotoxicity and inflammation. *Alcohol and Alcoholism*. 2009;44(2):141–147.
7. Butterworth RF, Kril JJ, Harper CG. Thiamine-dependent enzyme changes in the brains of alcoholics: relationship to the Wernicke-Korsakoff syndrome. *Alcoholism: Clinical and Experimental Research*. 1993;17(5):1084–1088.
8. Mayr JA, Feichtinger RG, Tort F, Ribes A, Sperl W. Lipoic acid biosynthesis defects. *Journal of Inherited Metabolic Disease*. 2014;37(4):553–563.
9. Jordan F. Current mechanistic understanding of thiamin diphosphate-dependent enzymatic reactions. *Natural Product Reports*. 2003;20(2):184–201.

{% hint style="info" %}
**Editorial note:** This page describes mechanisms and published evidence. It is not medical advice and does not recommend doses. Suggest corrections or new sources via the feedback link.
{% endhint %}
